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Abstract
Purpose Distant metastasis (DM) in patients with head and neck squamous cell carcinoma (HNSCC) is uncommon, but 
strongly deteriorates prognosis. Controversy exists regarding age as a predictor for the presence and development of DM. 
The aim of this study was to investigate age and other predictors for DM in HNSCC patients.
Methods From 1413 patients diagnosed with a primary HNSCC between 1999 and 2010 in a tertiary referral centre, patient, 
disease and pathological characteristics were extracted from patient files. Uni- and multivariable Cox regression analyses 
were performed to identify risk factors for DM as primary outcome.
Results DM occurred in 131 (9.3%) patients, of which 27 (1.9%) were diagnosed simultaneously with the primary tumour, 
27 (1.9%) were diagnosed synchronous, and 77 (5.4%) were diagnosed metachronous. The most common site of DM was 
lung (51.1%), followed by bone (19.1%) and liver (11.5%). Multivariable analysis identified male gender (HR = 1.95, 95% 
CI 1.23–3.10) hypopharyngeal tumours (HR = 3.28, 95% CI 1.75–6.14), advanced T-stage (HR = 1.61, 95% CI 1.09–2.38), 
poor differentiation grade (HR = 2.49, 95% CI 1.07–5.78), regional lymph node metastasis (HR = 5.35, 95% CI 3.25–8.79) 
and extranodal extension of regional lymph nodes metastasis (HR = 3.06, 95% CI 1.39–6.72) as independent prognostic 
factors for the presence or development of DM. No relation with age was found.
Conclusion Age is not related to the presence or development of DM. This study emphasizes the importance of screening 
for DM, especially in males, patients with hypopharyngeal tumours, advanced T-stage, histopathological poor differentiation 
grade, regional lymph node metastasis and extranodal extension.
Keywords Distant metastasis · Head and neck squamous cell carcinoma · Age · Hypopharyngeal cancer · Regional lymph 
node metastasis · Histological differentiation grade
Introduction
In patients with head and neck squamous cell carcinoma 
(HNSCC), the incidence of distant metastasis (DM) var-
ies between 3 and 52% [1–9]. When patients present with 
DM, the most affected sites are the lungs, followed by bone 
and liver [5, 10, 11]. In the last decades, detection of DM 
improved with the development of imaging techniques (e.g. 
fluorodeoxyglucose positron emission tomography (FDG-
PET) scan), leading to higher detection rates of late DM 
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[3, 12, 13]. The development of DM in HNSCC patients 
results in an infaust prognosis in most of the cases. Patients 
with DM receive palliative treatment and unfortunately 
around 90% decease within 12 months [2]. Patients that are 
diagnosed with DM prior to treatment are withheld form 
intensive curative treatment. Nevertheless, approximately 
11% patients undergo treatment with curative intent and are 
shortly afterwards diagnosed with DM [14]. In retrospect, 
these patients are unnecessarily treated with major conse-
quences for quality of life and healthcare costs [5]. On the 
other hand, routine screening for DM in all HNSCC patients 
does not seem rational, because of low incidence of DM in 
HNSCC patients.
It has been noted that different predictive factors could 
influence the development of DM, such as advanced T- and 
N-stage, specific tumour site, poor differentiation grade, 
extranodal extension and human papillomavirus (HPV) 
negative oropharyngeal SCC [1, 2, 4, 7, 8, 10, 12, 15, 16]. 
These predictive factors are globally recognised and adapted 
in the AJCC/UICC TNM staging system.
Decision making in elderly patients is very complex 
and decision regret is high in HNSCC patients who receive 
intensive therapy [17]. Consequently, the question arises 
whether older age is also a prognostic factor for DM. How-
ever, age as a risk factor for DM is less well-studied, and 
results are contradictory [1, 2, 4, 7–9]. Three studies identi-
fied age to be a predictive factor, however it remains unclear 
whether older [1] or younger [4, 9] patients are at higher risk 
for developing DM. Therefore, we aimed to identify age and 
other predictive factors for the development of DM by the 
analysis of a large cohort of HNSCC patients.
Patients and methods
Ethical considerations
The study has been registered in the Research Register of 
the University Medical Centre Groningen (UMCG). No 
approval of the Medical Ethical Committee was needed 
because of the retrospective nature of the study, in accord-
ance with Dutch Medical Research Law legislation.
Patients
This retrospective study includes a cohort of HNSCC 
patients diagnosed at the UMCG, a tertiary referral head and 
neck oncology centre in the Netherlands. Data were obtained 
from the Netherlands Cancer Registry (NCR), managed 
by the Netherlands Comprehensive Cancer Organization 
(IKNL). Included patients were 18 years or older, diagnosed 
with primary oral cavity, oropharyngeal, hypopharyngeal 
and laryngeal squamous cell carcinoma between 1999 and 
2010. Patients with cutaneous squamous cell carcinoma 
and other tumour types than squamous cell carcinoma were 
excluded. Patients presenting with multiple or second pri-
mary HNSCC were excluded, because of the uncertainty 
from which site a DM originated. The in- and exclusion of 
patients for this study are shown in Fig. 1.
Patients with >T1 tumours were standardly screened for 
regional and intrathoracic metastasis during the primary 
diagnostic work-up in our hospital by (earlier chest radiog-
raphy) computed tomography (CT) or magnetic resonance 
imaging (MRI). Additional MRI, CT, and/or PET were 
performed in case of clinical suspicion of DM or as part 
of staging when locoregional failure was diagnosed. Histo-
logical confirmation was not standardly performed but only 
conducted to distinguish between DM and second primary 
tumours, and was only performed in cases in which further 
diagnostics had clinical relevance.
Variables
Data from patient medical files were extracted and included 
patient characteristics (age, gender, oncological medical 
history and comorbidities), tumour characteristics (date 
of diagnosis, tumour site, TNM classification according to 
the AJCC 7th edition and date of DM) and detailed histo-
pathological information (differentiation grade, perineural 
growth, angioinvasion and extranodal extension of lymph 
node metastasis).
Comorbidity was scored using ‘The Adult Comorbidity 
Evaluation 27’ [18]. Perineural growth, angioinvasion and 
extranodal extension were only analysed in surgically treated 
patients, because nonsurgical cases were lacking complete 
histopathological information.
Depending of the time of discovery of the DM, DM 
was classified as: simultaneous (discovered with the pri-
mary tumour), synchronous (within the first 6 months after 
diagnosis), and metachronous (after 6 months of initial 
diagnosis).
Statistics
Descriptive statistics were used for patient, disease and 
detailed pathological characteristics. These factors were also 
stratified by DM during follow-up. To identify potential fac-
tors that might be associated with the occurrence of DM, 
univariable as well as multivariable Cox regression analyses 
were performed after checking whether the proportional haz-
ards assumption was met by evaluating log minus log plots. 
For both univariable and multivariable analyses, T-stage was 
grouped into early stage and advanced stage disease. Hazard 
ratios (HRs) and 95% confidence intervals (95% CIs) were 
reported; a 95% CI that did not include 1 or a p value below 
0.05 was considered statistically significant.
European Archives of Oto-Rhino-Laryngology 
1 3
Significant variables in univariable analyses were used 
for multivariable analysis. Because the multivariable model 
would include a substantially reduced number of cases when 
adding all selected variables in one model, four models with 
subgroups were generated. Model I included all patients 
whose age, gender, primary tumour site, T- and N-stage 
were known (n = 1399). Model II included patients of 
which the histological differentiation grade was also known 
(n = 997). Model III included patients of which angioinva-
sion was also known while differentiation grade was left 
out (n = 473). Model IV also included extranodal extension, 
while N-stage, differentiation grade and angioinvasion were 
left out (n = 186). Variables included in the final model were 
selected using a backwards step regression.
For the analysis on the relationship between DM and age, 
we divided patients in different age categories; <39, 40–49, 
50–59, 60–69, 70–79 and ≥80 years.
Kaplan–Meier curves were created to determine patients 
with and without DM for significant factors according to the 
multivariable models.
Fig. 1  Flow-chart in-/exclusion 
criteria
Consecutive series of patients diagnosed 
with primary head and neck malignancies 
between 1999 and 2010 in a tertiarty referral 
center
N = 2034
Patients with primary squamous cell 
carcinoma of the oral cavity, oropharynx, 
hypofarynx or larynx
N= 1413
Exclusion of patients with malignancies 
other than squamous cell carcinoma of the 
oral cavity, orophorynx, hypofarynx or larynx 
or patients with multiple tumors during 
follow-up
N= 621
Model I: Site, T-stage and N-stage known
N = 1400
Model II: Site, T-stage, N-stage and 
differentation grade kwown
N =998
Model III: Site, T-stage, N-stage and 
angioinvasion known
N= 498
Model IV: Site, T-stage, N-stage, and extra 
capsulair extension known.
N = 186
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Statistical analyses were performed using IBM SPSS Sta-
tistics 23 (IBM, Chicago, IL).
Results
A total of 1413 patients were included in the study, as shown 
in Fig. 1. Table 1 shows the patients and disease characteris-
tics. In 131 patients (9.3%) DM developed, of which 27 were 
diagnosed simultaneously with the primary tumour, 27 were 
diagnosed synchronous and 77 were diagnosed metachro-
nous. In these cases, the mean time between diagnosis 
and DM was 20.5 months (SD: 20.8; range 0–116 months, 
data not shown). Mean age of patients with DM was 
younger (59.6 years) compared to the patients with no DM 
(62.6 years). Patients were predominantly male (73.3%). 
Although the most common primary tumour site was the 
larynx, most DM originated from the oropharynx (38.9%), 
followed by the hypopharynx (25.2%), larynx (24.4%) and 
oral cavity (11.5%). Most primary tumours were diagnosed 
as a T1 tumour, which had the lowest DM incidence rate 
(7.6%). Early stage tumours (both T1 and T2) had lower 
DM incidence rate than advanced stage tumours (both T3 
and T4), 5.9 versus 14.7% respectively. Regional lymph 
node metastasis occurred in 41.1% of all patients. In most 
patients with DM, also lymph node metastases were detected 
(77.1%). Of the patients without lymph node metastasis 
(N0), 3.4% developed DM vs. 17.9% with positive regional 
lymph nodes. DM was found in 7.1% of well differentiated 
tumours, while 54.5% originated from tumours with mod-
erate differentiation and 38.4% with poor differentiation. 
In the DM group, 20.7% of the tumours showed perineural 
growth, versus 18.3% of the tumours in the group of patients 
without DM. Angioinvasion was observed in almost one 
third (30.8%) of the surgically treated patients who devel-
oped DM, versus 11.9% without DM. In surgically treated 
regional lymph nodes (n = 221), extranodal extension was 
more common in the DM group (70.0 versus 46.8%).
The most common site of DM was lung (51.1%), followed 
by bone (19.1%) and liver (11.5%) (data not shown).
For age analysis, categories were applied as described 
earlier. The number of DM was highest in the 50–59 year 
old patient population (n = 55; 12%), followed by the 60–69 
(n = 42; 11%), 40–49 (n = 15; 10%), 70–79 (n = 16; 6%), ≥80 
(n = 2; 2%) and ≤39 (n = 1; 3%) (p = 0.003), shown in Fig. 2. 
Age as either a continuous or categorical variable was not 
a significant predictor for DM in the multivariable model 
(Table 3), of which the results of the continuous variable 
are presented in Table 3.
Table 2 shows the results of the univariable analysis of 
potential factors influencing the presence or development 
of DM. Age, male gender, oropharyngeal and hypopharyn-
geal tumour site, advanced T-stage, positive N status, 
Table 1  Patient and disease characteristics, overall and stratified by 
DM at diagnosis or during follow-up
a M stage at diagnosis of the primary tumor
b Only surgically treated cases were included (n = 647)
c Only cases with surgically treated cervical nodes were included 
(n = 221)
All (%) DM (%) No DM (%)
1413 (100) 131 (9.3) 1282 (90.7)
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moderate and poor differentiation grade, the presence of 
angioinvasion and extranodal extension were identified as 
significant risk factors associated with DM. Comorbidi-
ties, larynx tumours and perineural growth were not identi-
fied as significant risk factors for DM.
Significant factors determined in univariable analysis 
were tested in a multivariable model, as shown in Table 3. 
Male gender, hypopharynx tumour site, advanced T-stage, 
positive N status, poor differentiation grade and extranodal 
extension were found to be independent predictive factors 
in multivariable analysis. Male patients had a higher chance 
to develop DM compared to women, with a hazard ratio 
(HR) of 1.95, p = 0.005. Hypopharyngeal tumours had a 
higher chance to develop DM with a HR of 3.28, p = 0.001. 
Advanced T-stage was also a significant predictor; with a HR 
of 1.61, p = 0.017. Regional lymph node metastasis was an 
independent predictor with a HR of 5.35, p < 0.001. Poor dif-
ferentiation grade was an independent predictor of develop-
ing DM, with a HR of 2.49 p = 0.015. Extranodal extension 
was an independent predictor with a HR of 3.06, p = 0.006. 
Due to a decrease in included cases in the different models, 
certain variables such gender, site, and T-stage lost signifi-
cance in the different models.
Significant variables in multivariable analysis are also 
presented in Kaplan–Meier curves in Fig. 3a–f. All variables 
were also significant in the Kaplan–Meier curves.
Discussion
In the present study, analysing a consecutive series in one 
of the largest homogenous published study cohort on this 
subject, younger age was associated with higher occurrence 
of DM in univariable analysis, however no relation between 
age and DM could be observed in multivariable analysis. 
We confirmed earlier identified independent predictive fac-
tors for the development of DM in HNSCC patients: male 
gender, location of the primary tumour at the hypopharynx, 
advanced T-stage, regional lymph node metastasis, poor 
differentiation grade and extranodal extension of regional 
lymph node metastasis.
In our study, 9% of patients developed DM. However, 
the reported incidence of DM in HNSCC varies widely in 
the published literature, between 3 and 52% [1–9]. This is 
mainly due to different study populations and study designs. 
The timing of DM diagnosis plays a crucial role in these dif-
ferences. Some papers study DM at the time of diagnosing 
the primary tumour, others during complete follow-up and 
others at autopsy [12]. In our study 20.6% of the DM were 
discovered at the same time as the diagnosis of the primary 
tumour.
Age by itself was significantly related to DM in univari-
able analysis. However, in the four tested models of the 
multivariable analysis as well as in additional analysis in 
Fig. 2  Percentage of DM per 
age category
12% 11% 6% 2% 10%3% 
p = 0.003 
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which patients were divided per age category and related 
with DM, no significant relation was found between age and 
DM. In a large study, including over 27,000 patients, older 
age was identified as an independent significant risk factor 
for DM, as well as primary site, nodal status, tumour size, 
and race [1]. However, the authors could not explain these 
findings and simply state that it is unclear why older patients 
are at high risk for DM. In contrast, in another large cohort 
of almost 2,000 HNSCC patients, younger age (<45 years) 
was found to be significantly associated with the risk of DM 
[4]. Hypopharyngeal localization, advanced T stage and/or 
N stage tumour, high histologic grade, and locoregional 
control were also related to the development of DM. This 
paper also could not clarify this age related finding. The 
authors presume that the role of younger age is of limited 
importance. In a more recently published study, also younger 
age at diagnosis was discovered a risk factor for developing 
pleural metastasis [9]. Likewise in this study, the authors do 
not give an explanation for this finding, concluding none of 
the above mentioned studies can interpret their age-related 
findings. In concordance with our results, few other studies 
also didn’t find an association between age and DM [7, 8]. 
A retrospective study analysing 130 advanced stage HNSCC 
identified clinically palpable neck disease (N1‐3), histologi-
cal evidence of metastatic nodal disease, extranodal exten-
sion, and three or more positive lymph nodes as predictors 
for developing DM [7]. Age, gender, primary site, history of 
radiation therapy, perineural invasion and tumour grade were 
not associated with a higher risk for DM. In another study, 
development of DM was not related with age, while N stage, 
T stage, and pre-treatment maximum standardized uptake 
value of the lymph node were strongly associated [8]. In a 
larger study including over 1,200 HNSCC patients, age was 
also not related to the frequency of DM [2]. None of these 
studies give an explanation for their age related findings. 
Discrepancies in age related findings between this study and 
the above mentioned studies could partly be explained by 
differences in study design. Some studies include a cross-
sectional study design, measuring DM only at diagnosis, 
while others performed a longitudinal study including both 
DM found at diagnosis as well as during follow-up after 
treatment. This explains the differences in reported inci-
dence of DM, which might also impact other results, such 
as age-related findings. Furthermore, the method of detec-
tion of DM is different among the above discussed studies. 
In most studies, description of the diagnostic process (like 
for example the applied imaging modalities) is lacking. Even 
within a study, work-up might vary due to differences in 
work-up between high-risk and lower-risk patients, which 
can also affect results. Differences in the epidemiological 
profile of patients among studies may also play a role. Our 
study population contains all HNSCC in a between 1999 and 
2010, while others included only advanced staged HNSCC 
patient, for instance specifically patients that underwent 
intensity-modulated radiotherapy or only patients with pleu-
ral metastasis. All these factors might have consequences for 
age analysis. Finally, limited sample size and thus the low 
power of many currently available studies may also partly 
explain conflicting results. However, also studies with large 
power found opposite results. All in all, the explanation 
for these different results concerning age and DM remains 
unclear.
Table 2  Univariable analysis of potential factors related to DM at 
diagnosis or during follow-up
Bold numbers represent significant values (p < 0.05)
a Early stage represents T1 and T2 tumours, advanced stage represents 
T3 and T4 tumours
b Only surgically treated cases were included (n = 647)
c Only cases with surgically treated cervical nodes were included 
(n = 221)
Variable HR (95% CI) p value
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In a recently published study, CART analysis (classifica-
tion and regression tree) was used to assess the impact of age 
on the survival of patients with HNSCC. Age was a signifi-
cant prognostic factor in predicting 5‐year disease‐specific 
survival, based on the uni‐ and multivariate analyses. How-
ever, in their CART model, the authors found that age plays 
only a minor role in HNSCC survival. This method revealed 
that the impact of age varied for different patient groups 
according to the presence or absence of other prognostica-
tors. This was different to our results; however, comparison 
between these studies is difficult as the cited study did not 
specifically investigated DM [19].
We identified the presence of regional lymph node metas-
tasis as the strongest independent predictor for DM. The 
important role of advanced N-stage as a predictor of DM 
development has already been described in numerous studies 
and is now also supported by our findings [1, 4, 7, 8, 10, 12, 
20]. Two of these studies also found extranodal extension 
an independent predictor of DM, in concordance with our 
results [7, 21]. While in one other study, extranodal exten-
sion was not a significant predictive factor for DM [22].
Hypopharyngeal tumours seem to give the highest risk of 
DM [1, 2, 4, 10, 20, 23]. In line with these findings, in our 
cohort patients with hypopharyngeal tumours had more than 
three times as high chance to develop DM compared to their 
counterparts with oral cancer.
In this study, advanced tumour stage and poor differentia-
tion grade were also found to be a significant independent 
predictor of DM. These factors were also described as high 
risk factors for DM in a review on DM in HNSCC [12].
Male gender was also found to be an independent predic-
tor of the development of DM. Others also investigated the 
relation between gender and the development of DM, most 
of these studies didn’t find male gender to be a significant 
predictive factor [1, 2, 5, 8, 9]. In other tumours this trend 
was also observed, for instance in malignant melanoma [24]; 
however, the explanation for this finding in HNSCC remains 
unclear.
Also the effect of angioinvasion and perineural growth 
on the development of DM was studied. Interestingly, nei-
ther angioinvasion nor perineural growth were significant 
independent predictors for DM, which is confirmed by two 
other studies [7, 10]. This finding is remarkable, as peri-
neural growth is considered to be a robust prognostic factor 
in cancer. However, it has found to be associated with an 
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Bold numbers represent significant values (p < 0.05). A (multivariable) backwards Cox regression analysis was performed to produce 4 different 
models to predict distant metastasis, based on statistically significant variables obtained in univariate analysis. Model I included patients with 
complete information on the variables age, gender, primary tumour site, T- and N-stage (n = 1399). Model II included the patients of model I 
of whom histological differentiation grade was also known (n = 997). Model III included patients of model II of whom angioinvasion was also 
known (n = 473). Model IV included patients of model I who also of whom histopathological capsular extension of cervical lymph nodes was 
also known (n = 186)
*Early stage represents T1 and T2 tumours, advanced stage represents T3 and T4 tumours
§Only surgically treated cases were included (n = 647)
¶Only cases with surgically treated positive cervical nodes were included (n = 221)
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increased risk of local recurrence and regional metastasis 
rather than with DM [25, 26].
Overall, the most frequent locations for DM in the present 
study were the lungs (51.1%), followed by the bones (19.1%) 
and the liver (11.5%). In line with our findings, this pat-
tern is also described in other studies [5, 10, 11]. In a large 
study, in which 832 patients with HNSCC were autopsied, 
most metastasis were found in the lungs (80%), followed by 
mediastinal nodes (34%), liver (31%) and bone (31%), indi-
cating that a clinical diagnosis of DM might be less precise 
than a pathological diagnosis [23]. Because of the very poor 
prognosis of patients with DM, in case of clinical suspicion, 
further diagnostics are often omitted as it has no clinical 
relevance.
In this study, DM only occurred in the first 120 months of 
follow-up. Typical Kaplan–Meier curves of DM in HNSCC 
show a rapid increase between months 0 and 8, a slow 
increase between months 8 and 24, and a plateau between 
months 24 and 84.5 indicating the absence of late distant 
metastasis [10].
This study included a very large series of consecutive 
cases and well-documented records. Because the retrospec-
tive nature of this cohort study, missing data were expected 
due to incomplete case records. However, our study popula-
tion was large and adequate to perform multivariable analy-
ses. Despite, some risk factors described in literature (e.g. 
lymph node size and bilateral and low neck level involve-
ment) [2, 21, 22, 27, 28] could not be included in our analy-
sis due to high number of missing data in the retrospective 
database. In addition, we did not have information on HPV 
status of the oropharyngeal tumours. Though, this would be 
interesting to analyse, as HPV-related oropharyngeal cancer 
is known to be associated with higher stage at diagnosis and 
more favourable outcomes [16].
Due to the improved locoregional control and the increas-
ing number of HNSCC survivors in the last decades, data 
on DM development gained more importance, recently [12]. 
On the other hand, recognizing patients with high chance 
of developing DM is essential, as these patients need to 
be screened before they undergo intensive treatment while 
costly imaging modalities can be spared in their counterparts 
who do not likely develop DM. According to the present 
study, regional lymph node metastasis is the strongest pre-
dictor for DM in HNSCC patients. However, more factors 
should be considered as indicators for screening, such as 
male gender, hypopharyngeal tumours, advanced T-stage, 
Fig. 3  a–f Kaplan-Meier curves of predictors of DM in HNSCC. 
Kaplan–Meier curves showing time to metastasis sorted on gender 
(a), the primary tumor site (b), T-stage, early: T1-2 vs. advanced: 
T3-4 (c), N-stage, N0 vs. N+ (d), histological differentiation grade 
(e) and extra capsular spread in cervical nodes (f)
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poor differentiation grade, regional lymph node metastasis 
and extranodal extension. Based on our study, a large, rep-
resentative and homogenous cohort, age does not play a role 
in the development of DM. Therefore, in all patients with 
high risk of DM development, extensive screening should be 
considered, irrespective of patients’ age. Screening should 
include the whole body, as metastasis may occur in the 
lungs, but also in the liver, the bones or in multiple organs. 
For this reason, the most appropriate method seems to be 
FDG-PET/CT. However, the method of screening was not 
the subject of this study.
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